Log in
Enquire now
Geneos Therapeutics

Geneos Therapeutics

Geneos Therapeutics is a plasmid-based Neoantigen-targeted Cancer Therapies.

OverviewStructured DataIssuesContributors

Contents

geneostx.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Oncology
Oncology
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Cancer
Cancer
Engineering
Engineering
Biology
Biology
Biotechnology
Biotechnology
...
Location
Plymouth Meeting, Pennsylvania
Plymouth Meeting, Pennsylvania
B2X
B2B
B2B
0
Number of Employees (Ranges)
1 – 100
Full Address
Plymouth Meeting, PA 19462, US
Investors
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Korea Investment Partners
Korea Investment Partners
Sante Ventures
Sante Ventures
Total Funding Amount (USD)
39,500,000
Latest Funding Round Date
March 25, 2022
Latest Funding Type
Series A
Series A
Country
United States
United States

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
17,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Geneos Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.